Dr. Dittrich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
San Diego, CA 92103Phone+1 858-657-8530
Education & Training
University of California (San Diego) Medical CenterFellowship, Cardiovascular Disease, 1982 - 1984- University of California (San Diego) Medical CenterResidency, Internal Medicine, 1978 - 1981
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1978
Certifications & Licensure
FL State Medical License 2022 - 2026
CA State Medical License 1979 - 2019
NV State Medical License 1981 - 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 2 citationsAngiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial.Kenta Nakamura, Timothy D Henry, Jay H Traverse, David A Latter, Nahush A Mokadam
Circulation. Cardiovascular Interventions. 2024-05-01 - 2 citationsEXACT Trial: Results of the Phase 1 Dose-Escalation Study.Thomas J Povsic, Timothy D Henry, Jay H Traverse, R David Anderson, Geoffrey A Answini
Circulation. Cardiovascular Interventions. 2023-08-01 - 13 citationsEpicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations.Thomas J. Povsic, Timothy D. Henry, E. Magnus Ohman, Carl J. Pepine, Ronald G. Crystal
American Heart Journal. 2021-07-02
Authored Content
- Prevalence, Predictors and Clinical Outcome of Residual Congestion in Acute Decompensated Heart FailureMarch 2018
- Prevalence, Predictors and Clinical Outcome of Residual Congestion in Acute Decompensated Heart FailureMarch 2018
- Prevalence, Predictors and Clinical Outcome of Residual Congestion in Acute Decompensated Heart FailureMarch 2018
Press Mentions
Cirius Therapeutics Announces Results from Phase 2b NASH Study Supporting Advancing to Phase 3 Development of MSDC-0602K; Data Accepted for Late Breaker Presentation at the Liver MeetingNovember 8th, 2019
Cirius Therapeutics Expands Scientific Advisory BoardJune 12th, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
